These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 33157558)
1. COVID-19 and Cardiovascular Comorbidities. Müller-Wieland D; Marx N; Dreher M; Fritzen K; Schnell O Exp Clin Endocrinol Diabetes; 2022 Mar; 130(3):178-189. PubMed ID: 33157558 [TBL] [Abstract][Full Text] [Related]
2. The Centrality of Obesity in the Course of Severe COVID-19. Liu D; Zhang T; Wang Y; Xia L Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917 [TBL] [Abstract][Full Text] [Related]
3. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico. Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264 [TBL] [Abstract][Full Text] [Related]
4. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19. Shah H; Khan MSH; Dhurandhar NV; Hegde V Acta Diabetol; 2021 Jul; 58(7):831-843. PubMed ID: 33587177 [TBL] [Abstract][Full Text] [Related]
5. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature. Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925 [TBL] [Abstract][Full Text] [Related]
6. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis. Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S mBio; 2021 Feb; 12(1):. PubMed ID: 33563817 [TBL] [Abstract][Full Text] [Related]
7. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients. Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857 [TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study. Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747 [TBL] [Abstract][Full Text] [Related]
10. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)? Pugliese G; Vitale M; Resi V; Orsi E Acta Diabetol; 2020 Nov; 57(11):1275-1285. PubMed ID: 32865671 [TBL] [Abstract][Full Text] [Related]
11. An Overview on COVID-19 and its Effect on Cardiovascular Diseases. Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study. Xiong S; Liu L; Lin F; Shi J; Han L; Liu H; He L; Jiang Q; Wang Z; Fu W; Li Z; Lu Q; Chen Z; Ding S BMC Infect Dis; 2020 Oct; 20(1):787. PubMed ID: 33092539 [TBL] [Abstract][Full Text] [Related]
13. Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic. Yuen KCJ; Blevins LS; Findling JW Endocr Pract; 2020 Aug; 26(8):915-922. PubMed ID: 33471683 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of Cardiovascular Comorbidities in Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Pooled Analysis of Published Data. Liu Y; Wu S; Qin M; Jiang W; Liu X J Am Heart Assoc; 2020 Sep; 9(17):e016812. PubMed ID: 32673529 [TBL] [Abstract][Full Text] [Related]
15. COVID-19: a conundrum to decipher. Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review. Deravi N; Fathi M; Vakili K; Yaghoobpoor S; Pirzadeh M; Mokhtari M; Fazel T; Ahsan E; Ghaffari S Rev Cardiovasc Med; 2020 Sep; 21(3):385-397. PubMed ID: 33070543 [TBL] [Abstract][Full Text] [Related]
17. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner. Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors. Yin T; Li Y; Ying Y; Luo Z BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678 [TBL] [Abstract][Full Text] [Related]
20. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study. Ge E; Li Y; Wu S; Candido E; Wei X PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]